Tuberculosis News and Research

Latest Tuberculosis News and Research

African giant pouched rat may be more effective than humans at detecting TB

The Wall Street Journal examines the use of the African giant pouched rat to detect tuberculosis (TB) in lab samples. A study published online in the Pan African Medical Journal last month found the rats are "better than human lab techs at identifying TB bacteria in a dollop of mucus," a finding that "holds promise for diagnosing tuberculosis in sub-Saharan Africa," according to the newspaper.

7 Sep 2011

International public health spending ignores neglected tropical diseases, some experts argue

The Bureau of Investigative Journalism examines what some experts are calling a serious inequity in public health spending, writing that neglected tropical diseases (NTDs) "together kill more people than maternal mortality and have a higher disease burden than malaria or tuberculosis (TB) and nearing that of HIV/AIDS. However, despite the severity of the situation, funding for NTDs is just a fraction of that spent on other diseases."

7 Sep 2011

Genetically modified M. smegmatis vaccine shows promise against TB

An experimental vaccine composed of a genetically modified bacterium closely related to the bacterium that causes tuberculosis (TB) has been found to protect mice against TB infection, according to a study appearing online September 4 in the journal Nature Medicine.

7 Sep 2011

NanoLogix to move R&D operations from Cincinnati to its headquarters in Hubbard

NanoLogix, an innovator in the accelerated detection and identification of microorganisms, announced today it will move its research and development operations from Cincinnati to its headquarters in Hubbard, Ohio.

6 Sep 2011

IKEPLUS immunization completely eliminates TB bacteria from infected tissues

A potential vaccine against tuberculosis has been found to completely eliminate tuberculosis bacteria from infected tissues in some mice. The vaccine was created with a strain of bacteria that, due to the absence of a few genes, are unable to avoid its host's first-line immune response.

5 Sep 2011

Einstein researchers develop tuberculosis vaccine candidate

Researchers at Albert Einstein College of Medicine of Yeshiva University report in the September 4 online edition of Nature Medicine that they have developed a tuberculosis (TB) vaccine candidate that proved both potent and safe in animal studies.

5 Sep 2011

Special journal edition chronicles 3-D structures of important antibacterial, bioterrorist targets

The September issue of the online scientific journal Acta Crystallographica: Structural Biology and Crystallization Communications (Acta Cryst F) will consist entirely of work done at the Seattle Structural Genomics Center for Infectious Disease (SSGCID), a consortium of researchers from Seattle BioMed, Emerald BioStructures, the University of Washington and Pacific Northwest National Laboratory.

2 Sep 2011

New clinical data on Bristol-Myers Squibb's NULOJIX to be presented at ESOT 2011 congress

Bristol-Myers Squibb Company today announced that new data on NULOJIX (belatacept) will be presented at the European Society for Organ Transplantation (ESOT) Congress on September 4 -7, 2011 in Glasgow, Scotland, United Kingdom.

2 Sep 2011

QIAGEN acquires Cellestis

QIAGEN N.V. today announced that its acquisition of all the ordinary shares in Cellestis Limited by a way of a scheme of arrangement has been implemented.

From QIAGEN Manchester Limited 29 Aug 2011

ABC News features six videos on global health issues

ABC News on Thursday posted six videos in its "World In 3" health series. The three-minute videos examine malaria in Uganda, neglected tropical diseases in Niger, pneumonia in the Philippines, sleeping sickness in the Democratic Republic of Congo, tuberculosis in South Africa and parasitic worms in Brazil.

26 Aug 2011

Faith-based organizations assist in fight against malaria

Natasha Bilimoria, president of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, discusses the importance of faith-based organizations in battling malaria in this post on the Bill & Melinda Gates Foundation's "Impatient Optimists" blog.

26 Aug 2011

Global Fund official says global economic downturn affecting resource mobilization

ABC Radio Australia's "Connect Asia" features an interview with Christophe Benn, director of external relations for the Global Fund to Fight HIV, Tuberculosis and Malaria. Benn said "it has become much more difficult to mobilize resources" since the 2008-09 economic downturn and "a great deal of mobilization, both of public and private donors" is needed to maintain ongoing projects that receive donations from the Global Fund.

26 Aug 2011

Boehringer Ingelheim, Lilly receive EU approval for linagliptin to treat type 2 diabetes

Boehringer Ingelheim and Eli Lilly and Company today received Marketing Authorization from the European Commission for linagliptin 5 mg film-coated tablets for the treatment of adults with type 2 diabetes.

26 Aug 2011

TB urine test developed by Indian researchers offers quicker, less invasive diagnosis

"The Delhi-based International Centre for Genetic Engineering and Biotechnology (ICGEB) and the Lala Ram Sarup Institute of Tuberculosis and Respiratory Diseases, collaborated with the National University of Singapore to develop" a urine test that "offers a less invasive diagnostic method for" tuberculosis (TB), SciDev reports.

25 Aug 2011

Global Fund to resume suspended grants to China

The Global Fund to Fight AIDS, Tuberculosis and Malaria, which "froze disbursements of its AIDS grant to China in November and all other grants in May over suspected misuse of the money and the government's reluctance to involve community groups, ... said Tuesday that it was lifting the freeze on financing to ensure that AIDS work in China continued while it worked with government officials, representatives from United Nations agencies and private groups to resolve the dispute," the Associated Press reports.

25 Aug 2011

A pain-free way of tackling dental decay

Researchers at the University of Leeds have discovered a pain-free way of tackling dental decay that reverses the damage of acid attack and re-builds teeth as new.

24 Aug 2011

Research may help explain why live attenuated influenza vaccine elicits protection

New research from the Trudeau Institute may help to explain why live attenuated influenza vaccine (LAIV), commonly known as FluMist, elicits protection.

24 Aug 2011

Fla., CMS discuss Medicaid managed care options; Calif. may shrink healthy families enrollment

A Florida proposal to shift nearly all of its 3 million Medicaid patients into managed care is emerging as a national test case for how lenient CMS will be as cash-strapped states look for savings in their most expensive health program. CMS and Florida officials met this week to address concerns about a five-county managed care pilot program that Florida is seeking to expand statewide.

23 Aug 2011

Research into TB medication may shorten treatment regimen

Research of the common tuberculosis (TB) drug pyrazinamide, which is used in combination with other medications to treat the disease in a six-month regimen, "has now revealed that the drug does kill the latent form of the microbe, which does not cause observable symptoms," VOA News reports.

23 Aug 2011

Hospital roundup: Catholic facilities losing nuns' leadership; Georgia infection rates; new VA system for Louisiana

In 1968, nuns or priests served as chief executives of 770 of the country's 796 Catholic hospitals, according to the Catholic Health Association. Today, they preside over 8 of 636 hospitals. ... The leadership shift has stirred angst in many Catholic hospitals about whether the values imparted by the nuns, concerning the treatment of both patients and employees, can withstand bottom-line forces without their day-to-day vigilance.

22 Aug 2011

Tuberculosis News and Research

Latest Tuberculosis News and Research

African giant pouched rat may be more effective than humans at detecting TB

International public health spending ignores neglected tropical diseases, some experts argue

Genetically modified M. smegmatis vaccine shows promise against TB

NanoLogix to move R&D operations from Cincinnati to its headquarters in Hubbard

IKEPLUS immunization completely eliminates TB bacteria from infected tissues

Einstein researchers develop tuberculosis vaccine candidate

Special journal edition chronicles 3-D structures of important antibacterial, bioterrorist targets

New clinical data on Bristol-Myers Squibb's NULOJIX to be presented at ESOT 2011 congress

QIAGEN acquires Cellestis

ABC News features six videos on global health issues

Faith-based organizations assist in fight against malaria

Global Fund official says global economic downturn affecting resource mobilization

Boehringer Ingelheim, Lilly receive EU approval for linagliptin to treat type 2 diabetes

TB urine test developed by Indian researchers offers quicker, less invasive diagnosis

Global Fund to resume suspended grants to China

A pain-free way of tackling dental decay

Research may help explain why live attenuated influenza vaccine elicits protection

Fla., CMS discuss Medicaid managed care options; Calif. may shrink healthy families enrollment

Research into TB medication may shorten treatment regimen

Hospital roundup: Catholic facilities losing nuns' leadership; Georgia infection rates; new VA system for Louisiana

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Tuberculosis News and Research

Latest Tuberculosis News and Research

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Newsletters you may be interested in